Trials / Completed
CompletedNCT02524496
Limited Access Protocol for the Use of Oral Cisapride
Limited Access, Open-label, Compassionate Use of Cisapride in the Treatment of Gastroparesis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Due to the lack of other drugs to treat gastroparesis Janssen and FDA approved the compassionate use of cisapride to treat patients who had no other effective therapy. For this observational study, 3 patients who had already been prescribed cisapride by outside physicians, were followed to determine the effectiveness of cisapride on their gastric emtpying.
Conditions
Timeline
- Start date
- 2001-03-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2015-08-14
- Last updated
- 2015-08-14
Source: ClinicalTrials.gov record NCT02524496. Inclusion in this directory is not an endorsement.